Category: Business conditions
-
Braeburn to Continue N. Carolina Facility Despite HB2
17 May 2016. Braeburn Pharmaceuticals, a developer of treatments for opioid addiction, will continue with its plans to build a research and manufacturing facility in North Carolina, despite its opposition to a recent state law overturning local ordinances prohibiting discrimination against the LGBT (Lesbian, Gay, Bisexual and Transgender) individuals. The company says the state’s Attorney…
-
Drug Pricing Reform Even Big Pharma Might Like
2 May 2016. At a press event in Washington, D.C. last week, Representative Lloyd Doggett of Texas, a champion of lower prescription drug prices, took aim at drug companies and their business practices. “An unaffordable drug is 100 percent ineffective,” Doggett told an audience at Center for American Progress on 26 April. He noted that…
-
U.S. Energy Use Declines in 2015, Renewables Gain
20 April 2016. Energy use by Americans in their homes and businesses declined in 2015 from the previous year, due to a sharp drop in coal burned for electric power, among other factors. The findings were published in an annual accounting of national energy supply and demand by Lawrence Livermore National Laboratory, based on data…
-
Flair4IT Helps Cloud Computing Become Mainstream in the EU
– Sponsored Content – 11 April 2016. Flair4IT, a UK based IT agency, has been working on making the cloud more mainstream in the EU. They have looked specifically at software applications and infrastructures. To enable the market to become more aware of cloud computing, and to make it as common as what it is…
-
Pharmacy Interventions Shown to Boost Meds Adherence
4 April 2016. Actions by community pharmacists and other customer-assistance programs at Walgreens pharmacies were shown to improve customers’ adherence to medications and reduce their health care costs. Results of the study conducted by health analysts at Walgreens appear in the 1 April issue of the journal Population Health Management. The research team led by Michael…
-
Harnessing Big Data for Precision Medicine
13 February 2016. Precision medicine aims to match individualized genomic data with therapies to provide personalized treatments for people with disease. A panel today (13 February) at the American Association for Advancement of Science or AAAS 2016 annual meeting, described how big data — finding insights in large data sets — help make precision medicine…
-
What it Takes to Innovate in the Old Economy
12 February 2016. Innovation is important throughout the modern economy, particularly in established industries that may lack the excitement of hot new sectors like biotechnology. A panel at the American Association for the Advancement of Science, or AAAS 2016 annual meeting today (12 February) in Washington, D.C. examined ways of creating innovation in these legacy…
-
Medical Industry Payment Recipients Identified
5 January 2016. An analysis of industry payments to physicians shows cardiovascular specialists and neurosurgeons were the specialties most likely to receive payments from pharmaceutical and medical device companies. The findings appear in this month’s issue of the journal Mayo Clinic Proceedings. The research team from University of California in San Diego, led by radiation…
-
More PhDs Heading to Industry, Improve Earnings
11 December 2015. An analysis of recent grant-funded Ph.D. recipients shows a large number of new doctorates taking jobs in industry, particularly with larger companies paying higher salaries. The study of federal and other grant-supported doctorates, conducted by researchers at several universities and policy institutes, appears in today’s issue of the journal Science (paid subscription…
-
Study: Records Database Offers Clinical Trial Savings
3 December 2015. A cost-benefit analysis shows pharmaceutical companies could reap sizable savings in their planning and conduct of clinical trials if they made regular use of a European electronic health records database. The study, led by Data Mining Institute in Geneva, Switzerland with co-authors from several pharmaceutical companies, appears in the January 2016 issue…